Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.29 - $0.89 $12,540 - $38,485
-43,242 Reduced 2.88%
1,455,882 $395,000
Q2 2022

Aug 15, 2022

SELL
$0.62 - $1.1 $92,522 - $164,153
-149,230 Reduced 9.05%
1,499,124 $1.15 Million
Q1 2022

May 16, 2022

BUY
$1.07 - $2.71 $123,222 - $312,086
115,161 Added 7.51%
1,648,354 $1.76 Million
Q4 2021

Feb 14, 2022

BUY
$1.87 - $2.91 $591,436 - $920,363
316,276 Added 25.99%
1,533,193 $2.91 Million
Q3 2021

Nov 15, 2021

SELL
$3.01 - $4.12 $1.61 Million - $2.2 Million
-534,401 Reduced 30.51%
1,216,917 $3.66 Million
Q2 2021

Aug 16, 2021

BUY
$3.62 - $5.23 $3.05 Million - $4.4 Million
841,970 Added 92.59%
1,751,318 $6.85 Million
Q1 2021

May 17, 2021

BUY
$3.94 - $8.19 $756,420 - $1.57 Million
191,985 Added 26.76%
909,348 $4.61 Million
Q4 2020

Feb 16, 2021

BUY
$3.99 - $5.7 $402,730 - $575,329
100,935 Added 16.37%
717,363 $2.93 Million
Q3 2020

Nov 16, 2020

SELL
$4.38 - $6.43 $1.7 Million - $2.5 Million
-388,820 Reduced 38.68%
616,428 $3 Million
Q2 2020

Aug 14, 2020

BUY
$3.0 - $6.9 $543,780 - $1.25 Million
181,260 Added 22.0%
1,005,248 $5.57 Million
Q1 2020

May 14, 2020

BUY
$2.36 - $9.86 $1.94 Million - $8.12 Million
823,988 New
823,988 $2.7 Million
Q4 2019

Feb 14, 2020

SELL
$2.69 - $4.92 $51,561 - $94,306
-19,168 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$2.59 - $4.16 $49,645 - $79,738
19,168 New
19,168 $79,000
Q4 2018

Feb 14, 2019

SELL
$2.28 - $7.15 $153,393 - $481,037
-67,278 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$3.85 - $7.35 $176,580 - $337,107
45,865 Added 214.19%
67,278 $491,000
Q2 2018

Aug 14, 2018

SELL
$3.7 - $5.65 $47,822 - $73,026
-12,925 Reduced 37.64%
21,413 $79,000
Q1 2018

May 15, 2018

SELL
$3.65 - $5.2 $285,218 - $406,338
-78,142 Reduced 69.47%
34,338 $132,000
Q4 2017

Feb 14, 2018

SELL
$3.4 - $4.15 $354,623 - $432,849
-104,301 Reduced 48.11%
112,480 $405,000
Q3 2017

Nov 14, 2017

BUY
$3.55 - $5.25 $769,572 - $1.14 Million
216,781
216,781 $856,000

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.